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Producing ‘designer cells’ with specific functions is potentially feasible in the near future. Re-
cent developments, including whole-cell models, genome design algorithms and gene edit-
ing tools, have advanced the possibility of combining biological research and mathematical
modelling to further understand and better design cellular processes. In this review, we will
explore computational and experimental approaches used for metabolic and genome de-
sign. We will highlight the relevance of modelling in this process, and challenges associated
with the generation of quantitative predictions about cell behaviour as a whole: although
many cellular processes are well understood at the subsystem level, it has proved a hugely
complex task to integrate separate components together to model and study an entire cell.
We explore these developments, highlighting where computational design algorithms com-
pensate for missing cellular information and underlining where computational models can
complement and reduce lab experimentation. We will examine issues and illuminate the next
steps for genome engineering.
Introduction
Synthetic biology is the rational design and engineering of cells and cellular systems using geneticmanipu-
lations [1,2]. It is divided into three fields [3]: DNA-based device construction (production of functioning
biological components to be inserted into cells), synthetic protocell development (construction of rudi-
mentary representations of living cells), and genome-driven cell engineering. For more about DNA-based
device construction principles see Brophy andVoigt [4], and for an introduction to protocell development
see Dzieciol and Mann [5]. In this review, we will focus on genome-driven cell engineering (see Box 1 for
key terms).
Genome-driven cell engineering encompasses both metabolic engineering (control of cellular produc-
tion processes) and genome engineering (production ofminimal genomes, recoded genomes, and cellular
chassis/factories). It encompasses diverse types and scales of genetic modifications and underscores the
genome as the major driver of cellular events [3].
Metabolic engineering attempts to improve titre, accumulation rate, and yield of a specific metabolite,
often from microorganisms in an industrial setting [6]. Genome engineering attempts to: understand
(comprehending biological systems by trying to engineer them [7], e.g. minimal genomes), reduce risks
(restricting bacteria to specific media [8], e.g. recoded genomes), and improvemetabolite production (e.g.
‘optimal’ chassis cell development for metabolite production [9]).
Here, we review metabolic engineering and genome engineering from both biological and computa-
tional perspectives. Metabolic engineering, with established in silico design and simulation (hundreds
of models, tens of algorithms) [10,11] and in vivo construction methodologies (hundreds of strains of
several bacterial species) [12], could inform the future of genome engineering, given the development of
whole-cell mathematical models [13], genome design algorithms [14,15], and CRISPR-cas9 gene editing
techniques [16–18]. Finally, we examine issues and the next steps for genome engineering.
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Box 1 Key terms
Genome engineering: Extensive and intentional genetic modification of a replicating system for a
specific purpose [19].
Minimal genomes: Reduced genomes containing only the genetic material essential for survival, with
an appropriately rich medium and no external stresses. No single gene can be removed without loss
of viability [20].
Recoded genomes: Genomes with codon/s that have been freed, substituting codons for synony-
mous codons that encode the same amino acid, so that they can be assigned to new functions
[21,22].
Platform cell/cell factory/chassis (interchangeable): A bacterial species that can efficiently convert
rawmaterials into a product of interest, through genome engineering or hosting genetic components
[6,23–26].
Multiplex gene editing: Simultaneous introduction of multiple distinct modifications to a genome [27].
Algorithm: Series of steps or rules to attempt to solve a problem, often implemented in a computer.
Model: Mathematical description of a system.
Metabolic ﬂux: Metabolic reaction rate (i.e. turnover of molecules through a metabolic reaction).
Flux vector: A vector where each element corresponds to the metabolic flux of a reaction in the model.
Genome-scale biological models: Category of models containing: metabolic models, transcription
regulatory networks, protein–protein interaction networks, integrated cellular models, and whole-cell
models [11].
Genome-scale metabolic models: Models representing all active reactions in a cell/organism as a
matrix of stoichiometric coefficients of each reaction, and linking reactions with gene products that
catalyse them. Abbreviated to GSMMs or GEMs [28,29].
Whole-cell models: Describe the life cycle of a single cell, modelling individual molecules and inter-
actions, and includes the function of every known gene product [13].
Metabolic engineering in vivo
Metabolic engineering enhances the production of native or introduced metabolites, often in a microbial strain [6].
Genetic edits are used to introduce ormodify the required pathway and take control of coremetabolism, cellular regu-
lation, and stress responses [6,12]. Applications are wide ranging, including fuels, feed additives, and pharmaceuticals
[12,30], and determine the most appropriate microorganism for production (see Table 1).
Only a small number ofmicroorganisms are ‘industry ready’, such as:Escherichia coli (E. coli),Bacillus subtilis (B.
subtilis), Streptomyces sp., Pseudomonas putida, Corynebacterium glutamicum [6], Saccharomyces cerevisiae
and Aspergillus niger [12]. Requirements for industrial microorganisms are simple nutritional needs, fast and effi-
cient growth, high resistance to extreme physical and chemical conditions, and efficient secretion systems [6]. Also
required are sufficient genetic and metabolic knowledge and a range of genetic tools (e.g. promoters and terminators
with varying expression levels, and well-characterised plasmids for precise manipulations). Due to the development
of CRISPR-cas9 gene editing tools [31,32], a number of novel bacterial species are now usable, including Vibrio na-
triegens (has the shortest known doubling time, at 15 min), and Roseobacter and Halomonas (marine species with
salt tolerance) [6]. Metabolic engineering has recently been reviewed for E. coli [33] and B. subtilis [34].
Themetabolic production pathway is constructed, reconstructed, or tweaked in the strain, and can then be iterated
upon to produce improvements in titre, rate, and yield. There are six strategies [34] for improving these: (i) modular
pathway engineering, which divides up the production pathway to produce and combine modules with different ex-
pression levels [35]; (ii) cofactor engineering, in which metabolic flux to the desired products is enhanced through
gene edits that alter non-protein cofactor levels [36]; (iii) scaffold-guided protein engineering, where the spatial lo-
cations of proteins in the cell are modified to increase local concentrations of intermediates [37]; (iv) transporter
engineering, which improves the import of substrates [38] and export of products [39]; (v) dynamic pathway anal-
ysis, which identifies unknown network interactions and promotes or suppresses them to increase levels of product
[40]; and (vi) evolutionary engineering, which mimics natural evolutionary approaches to produce greater amounts
of product [41–43].
The development of an ‘industry ready’ strain takes several years and is costly. Strains for Artemisinin and
1,3-propanediol production took 10 years and $50 million, and 15 years and $130 million, to develop respectively
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Table 1 A selection of microorganisms used for metabolite production
Microorganism Primary feature Applications Product examples Strain examples






Based on K-12 and B ancestor
strains. Derivatives of MG1655,
W3110, BW25113.
Speciﬁc strains: BL21 Rosetta,
DH1, ATCC 31884, DH10B








Speciﬁc strains: 168, RH33,
BSUL08, 1A1, E8, KU303
Pseudomonas putida Chemical resistance Harsh conditions and toxic
product production
3-methyl-catechol, anthranilate,
cinnamic acid, PHAs, phenol,
o-cresol, styrene, terpenoids,
vanillate
Speciﬁc strains: KT2440, EM42,
Gpo1, S12
Cyanobacteria Photosynthetic Light-driven production 1-butanol, 1,3-propanediol,
bisabolene, ethanol, farnesene,
isoprene, isopropanol, PHAs
Speciﬁc strains: PCC- 6803,
PCC-7942. PCC-7002
Information collated from Nielsen and Keasling [12] Calero and Nikel [6], Gu et al. [34], and Pontrelli et al. [33].
[12], though sales of metabolic products are expected to reach $6.2 billion by 2020 [44]. The time and cost is due to
complex interactions and regulation inmetabolism.Metabolite intermediates and products can cause toxicity and act
as inhibitors of other reactions, or be misrouted or modified by unrelated enzyme reactions, leading to decreasing
titre, rate, and yield [6].
Recently, the availability of accurate, genome scale metabolic models, refined with data captured using omics tech-
nologies, has begun to overcome these limitations and support rounds of in silico design and in vivo construction.
[6,34].
Metabolic engineering in silico
Constraint-based metabolic models
Recent advances have allowed the reconstruction of genome-scale metabolic networks, and subsequently in silico
models which can predict cellular phenotypes.Metabolicmodels are based on biological knowledge and experimental
data; metabolic kinetic models describe how metabolites vary in time using differential equations, while metabolic
constraint-based models formalise behaviour at steady-state (i.e. metabolite production is equal to metabolite loss)
[45]. There are currently very few genome-scale kinetic models, due to the lack of experimental data for enzyme rate
parameters, but the static nature of constraint-based models means they require significantly fewer parameters to
construct, and so are more widely used. For this reason, we will mainly review constraint-based models.
Genome-scale metabolic models (GSMMs/GEMs) aim to form a solution space of flux values for each reaction in
a metabolic model (see Orth et al. [46] for more details), or can give insight into the behaviour of the system through
network analysis. These models consist of a stoichiometric matrix and a set of biologically feasible constraints for
reactions (Figure 1).
There are currently 113 bacteria, 57 eukaryote and 8 archaea curated GEMs available at UCSD Systems Biology
[47], see Figure 2. Tools for automatically generating GEMs have been developed, first modelSEED [48] and the most
recently CarveMe [49]. CarveMe begins with a universal model consisting of 2383 metabolites and 4383 reactions,
formulated from the BiGG database [50,51]. This can be stripped down to become ametabolic model for any specific
organism, using its annotated genome. There are multiple other automation tools available: AuReMe [52], Merlin
[53], MetaDraft [54], Pathway Tools [55], and Raven [56], which have been recently reviewed [57].
Exploring and analysing the steady-state solution space
There are numerous ways to simulate and analyse metabolic models, depending on the desired information. Elemen-
tary flux modes (EFMs) can be found, based on the stoichiometric matrix—these are the set of non-decomposable
reactions that trace input metabolites to output metabolites which can be used to break a metabolic network into
its component pathways [58]. In the context of metabolic engineering, these can be analysed to choose reactions to
disrupt in order to direct cell resources towards specific metabolites. Alternatively, the fluxes through each reaction
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Figure 1. A toy metabolic network
Si are the substrates and ri are the reaction rates. The network can be represented as a stoichiometric matrix (whose columns and
rows correspond to reactions and metabolites, respectively), and a system of equations.
Figure 2. Creation and timeline of bacterial GEMs over the past two decades
More complex genome-scale computational models (such as metabolic and macromolecular expression (ME) models and the first
whole-cell model), modelling automation tools (ModelSEED and CarveMe) and the ME software frameworks COBRAMe are also
included. 2001 did not see any models created.
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Figure 3. A schematic of the feasible region found through constraint-based modelling
Where vi are fluxes of the system and form a flux polyhedron. The flux values that optimise the objective function can be found by
looking at the extreme edges of the polyhedron, and selecting the point that fits the optimisation criteria.
when the system is at steady state can be found, either throughMonte Carlo sampling [59] or, more commonly, by flux
balance analysis (FBA). The solution space of the system at steady-state can be found by combining the constraints
on the system to form a region which can be analysed, as shown in Figure 3.
To perform FBA, first an objective function is defined that canmaximise orminimise the flux through any reaction
in the system.When simulating a wild-type unicellular organism in the exponential growth phase, the rate of biomass
production is maximised as a proxy for cellular fitness [60], and used as the objective function. This is formulated
as a ‘pseudoreaction’, meant as the sum of the different biomass components (e.g. amino acids, fatty acids, vitamins,
and cofactors); the flux through which is maximised. Other objective functions can be used for different purposes:
for example, minimisation of ATP production [61], or optimisation of several reactions in parallel.
FBA optimisation generates flux vectors that are used to optimise a defined objective function. The flux vectors
give insight into the dynamics of the system when equilibrium is reached, indicate which pathways the metabolites
are involved in, and can also predict the behaviour of the simulated cell when grown in different culture conditions.
FBA is available in the COBRA (constraint-based reconstruction and analysis) toolbox for Python or MATLAB
numerical computing environments. For an overview of the COBRA ecosystem see Lewis et al. [62].
Alternative methods to optimise the solution space
GEMs can be used for metabolite optimisation by analysing the effects of adding or removing genes. FBA can be
used to directly calculate fluxes in cells with gene knockouts, or FBA wild-type fluxes can be used as input for other
methods to calculate fluxes after gene knockouts: MOMA (minimisation of metabolic adjustment [63]) and ROOM
(regulatory on/off minimisation of metabolic flux [64]). While FBA picks a solution that optimises a given objective
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function, MOMA and ROOM output a solution which minimises the distance between the wild-type and the altered
metabolism fluxes, or the number of changes in flux respectively. Given that a strain after a knockout is not a result
of evolution, the assumption of the FBA objective function mimicking evolution may no longer be relevant and so
both MOMA and ROOM account for the cell behaviour immediately after in vivo knockouts, which can be different
from cell behaviour over a longer time scale [65].
Predicting gene essentiality using GEMs and algorithms
Metabolic models can be used also to predict gene essentiality—gene knockouts can be simulated and then cell sur-
vival assessed based on the end production of biomass (i.e., if the simulation results in zero biomass production, the
cell is presumed to be dead and therefore the knocked-out gene is essential). This has successfully been shown for
E. coli strains such as MG1655, where gene deletions simulated in silico correctly predicted the essentiality of 86%
of single gene deletions [66]. Similar gene essentiality testing has been performed with FBA models of other organ-
isms, including Helicobacter pylori [67], Saccharomyces cerevisiae [68], B. subtilis [69], and C. glutamicum [70],
showing the accuracy of these models.
Further Development of GEMs
GEMs can also act as a springboard for more detailed cellular models that take into account transcription processes.
These extended models, still in early stages of development, have not yet improved the accuracy of standard FBA
models [49]. More recently, macromolecular expression (ME) has been incorporated (ME-models) to integrate tRNA
charging, transcription, and translation reactions with metabolic reactions. The metabolic reactions are coupled with
the macromolecular synthesis reactions of the enzymes that catalyse them, and the synthesis reactions for transcrip-
tion and translation components (e.g. mRNA and proteins) are formed from the metabolic biomass production. The
COBRAMe framework [71] aids generation of MEmodels, for example an E. colimodel (iJL1678b-ME) that is more
efficient than the first E. coliMEmodel (iOL1650-ME [72]), containing 1/6 variables and solving in 1/36 of the time.
The main limitation to this approach is the lack of well-curated databases: while genome and gene product infor-
mation can be retrieved (e.g. using KEGG [73] and Genbank [74]), no single database contains rate parameters for
transcription and translation, necessary for ME model parameterisation [75].
Metabolic engineering applications: constraint-based modelling and
metabolic network analysis
As discussed above, GEMs can be used to study wild-type cell behaviour, as well as investigate the effects of gene
knockouts. Another application is formetabolic engineering, where algorithms can use GEMs to predict genes within
the model to knockout, amplify or inhibit, in order to produce a pre-defined goal of overproduction of somemetabo-
lite.
Metabolic engineering using Elementary Flux Modes (EFMs)
As well as providing scope for analysis of metabolic networks, EFMs can be used to isolate pathways that can be dis-
rupted to force a cell to overproduce a metabolite. As EFMs find minimal pathways through the metabolic network,
the paths from an input substrate to a chosen metabolite and its efficiency (i.e. the stoichiometry and length of the
chain of reactions) can be found. Competing reaction pathways can then be found and removed, thereby producing a
streamlined strain with minimal functionality. Although this process involves significant computational power, espe-
cially for genome-scale models, it has been shown to have success in improving lysine production in C. glutamicum
[76].
Metabolic engineering using nested linear programming-based methods
Whereas FBA, MOMA and ROOM take gene modifications as their input and output a corresponding flux distribu-
tion, other algorithms designed specifically for metabolic engineering take a metabolite (other than biomass) as their
input, and output a set of gene modifications that optimise its production.
For example, OptKnock maximises the production of a specified metabolite and biomass by deleting genes to
re-route metabolites through certain reaction pathways [77]. Genome designs for the overproduction of succinate
and lactate in silico using OptKnock were consistent with laboratory results [77].
Several algorithms for metabolite optimisation use linear programming and couple cell growth and biochemical
production using bilevel mixed-integer linear program (MILP), a nested framework where an outer optimisation
problem (e.g. maximise metabolite) is constrained by another inner optimisation problem (e.g. maximise biomass),
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Figure 4. Bilevel linear programming
The nested structure of the bilevel linear programming algorithms, where the inner problem optimises for a cellular objective function
and the outer problem optimises for some metabolic engineering objective.
Table 2 Metaheuristic algorithms for analysis of metabolic models and metabolic engineering
OptGene (Patil et al., 2005) [86] Uses a genetic algorithm (the outer problem) to iteratively run FBA (the inner problem) with different knockout
combinations to maximise metabolite production
RegKnock (Xu, 2018) [87] Uses a genetic algorithm and a regulatory FBA model [88] for the inner problem, where extra constraints are
placed on the system to model gene regulation events to maximise chosen metabolite production
FOCuS (Mutturi, 2017) [89] Divides the total reactions into smaller groups, which are individually evaluated, as a pre-processing step,
followed by a combination of ﬂower-pollination algorithm [90] and clonal selection algorithm [91] to maximise
metabolite production
GACOFBA (Salleh et al., 2015) [92] Uses a combination of ant colony optimisation and a genetic algorithm as the outer problem to maximise
metabolite production
as shown in Figure 4. This two-stage optimisation problem can be intractable; therefore, OptKnock [77], OptORF
[78], and RobustKnock [79] reduce the bilevel problem to a single level problem using duality theory (i.e. an approach
that enables optimal solutions of two problems to be found by setting their objectives equal to one another).
Alternatively, ReacKnock [80] uses Lagrangian multipliers (a process for non-linear optimisation) to allow specif-
ically equality constraints, which can then reformulate the bilevel problem into a single level problem [81].
EMILiO [82] also uses linear programming, but iteratively: it begins by pruning the metabolic network to select a
subset of the flux constraints that will maximise themetabolite production rate, then it prunes the subsets tominimise
the number of reactionmodifications. It will then output knockout, activation or inhibitionmodifications to produce
the desired metabolite overproduction.
Optimising metabolism using reaction ﬂux regulation
OptReg [83] and OptForce [84] output reactions to be up-regulated or down-regulated to create a desired flux distri-
bution. They first calculate upper and lower bounds for every reaction flux in the system by iteratively changing the
objective function to maximise and minimise each reaction, then compare these ranges to the flux distribution of a
metabolism that overproduces a targeted metabolite. It is possible to identify the reactions that require regulation to
transform their behaviour into that of the system that overproduces the targeted metabolite. OptForce has the addi-
tion of predicting knockouts as well as regulation changes, and also minimises the amount of interventions needed
to achieve metabolite overproduction.
Optimising metabolism using metaheuristic algorithms
Other approaches are based on metaheuristic algorithms [85] (Table 2), which are high-level methods used to search
a solution space. They are particularly powerful when sampling a large solution space using incomplete informa-
tion, and often use optimisation methods that contain a degree of stochasticity. Multiple E. coli strain GEMs contain
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Figure 5. Comparison of metabolic engineering algorithms/frameworks features
Black rectangles indicate feature presence, white rectangles indicate absence.
over 2000 reactions, but the possible combinations for only five gene knockouts is 1015, making the solution space
huge. However, metaheuristic algorithms do not guarantee a globally optimal solution and they require significant
computational power.
Optimising metabolism using non-native reactions and neighbourhood
searching
Additional approaches for algorithmic metabolite optimisation include OptStrain [93], which searches through the
KEGG database to find non-native reactions to add to a GEM to optimise metabolite production.
Genetic Design through Local Search (GDLS) [94] iteratively searches through possible solutions (e.g. knockout
sets) that differ from the starting conditions using a neighbourhood search (ametaheuristicmethod for searching over
the solution space by exploring solutions in the ‘neighbourhood’ of the current solution), and stores the best solutions
in each iteration. Whereas bilevel linear programming approaches scale exponentially, the runtime for GDLS scales
linearly with the number of knockouts, making it more efficient.
Metabolic models and algorithms summary
Choosing an algorithm to use (Figure 5) has to take into account the experimental methodologies available (i.e.
the number of knockouts which can be performed), and the available computational power (significantly higher for
metaheuristic algorithms). Also, the validity of results has to be critically considered given the accuracy of reaction
databases used by some algorithms (e.g. OptStrain), and possible unrealistic results in simulated flux distributions
when using entirely stoichiometric representations of metabolic pathways.
Genome engineering in vivo
Genome engineering is the production of modified genomes using either a prescriptive genome design or a clear
laboratory-based algorithm to design gene edits, and accurate genetic tools that can be used repeatedly.
Genome engineering builds on historical gene essentiality research (see Figure 6). The sequencing of small bacterial
genomes [95,96] led to comparative genomics, initially between pairs of bacteria [97], then including greater numbers
of bacteria as genome sequencing increased, which led to the development of minimal gene sets [97–99]. However,
as the number of microorganisms increased, the number of shared genes decreased: by the thousandth genome se-
quenced only four genes were shared across all sequenced bacteria [100]. This trend is true even among closely re-
lated species, 20Mycoplasma strains were found to share only 196 genes [101]. This is due to non-orthologous gene
displacements (NOGDs), independently evolved or diverged proteins that perform the same function but are not
recognisably related [20,97]. This comparative work continues to be built on computationally, analysing the growing
number of genomic datasets for key features that could match NOGDs (see persistent gene concept [102]); neverthe-
less, genome engineering has moved to a species-specific focus.
Single gene knockout studies (implemented by systematic removal, inactivation, transposon mutagenesis, and an-
tisense RNA [103]) are still used to provide an initial assessment of gene essentiality, but further work is required, as
gene essentiality has been shown to depend both on the environmental context (i.e. how cells are grown) [104] and
genomic context (i.e. what other genes present) [105].
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Figure 6. An incomplete history of genome engineering in microorganisms
Consequently, non-essential and essential classifications have been expanded to no essentiality, low essentiality,
high essentiality, and complete essentiality [105], with other important classifications for genome engineering in-
cluding quasi-essential (removal reduces growth rate substantially [106]), synthetic lethal (removal can kill the cell
depending on the presence/absence of related genes [107,108]), and synthetic rescue (multiple genes that are essential
individually, that can be removed together [109,110]). This redefinition of essentiality has underlined the existence
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 3 Genome-driven cell engineering examples
Genome Reductions
Microbe Reduction Beneﬁts
JCVI-Syn3.0 (Hutchison et al., 2016) [106] 50% Smallest genome of any autonomously replicating cell. Has a doubling time of ∼180
min, four to ﬁve times faster than M. genitalium (12–15 h [20])
E. coli 33a (Iwadate et al., 2011) [113] 39% -
E. coli DGF-298 (Hirokawa et al., 2013) [9] 35% Better growth ﬁtness and cell yield, in a rich medium, than the wild-type strain, and has
a more stable genome
B. subtilis PG10 and PS38 (Reuß et al., 2017) [112] 36% Subsequently used for production purposes, as has traits that are favourable for
producing ‘difﬁcult-to-produce proteins’, overcoming several bottlenecks (secretion
process and unstable product) [122]
E. coli 16 (Hashimoto et al., 2005) [123] 30% -
B. subtilis MGIM (Ara et al., 2007) [124] 24% Little reduction in growth rate and comparable enzyme productivity
E. coli MGF-01 (Mizoguchi et al., 2008) [114] 22% Better growth rate resulting in 1.5-fold cell density and 2.4-fold greater threonine
production compared with the wild-type strain
B. subtilis MBG874 (Morimoto et al., 2008) [125] 20% Extracellular cellulase and protease production were 1.7- and 2.5-fold higher.
Production period was elongated and carbon utilisation improved
E. coli MS56 (Park et al., 2014) [126] 23% Insertion sequence free, making it more genomically stable, predicted to increase
production of recombinant proteins
E. coli MDS43 (Posfai et al., 2006) [127] 15% Showed genome stabilisation and increased electroporation efﬁciency, comparable
with E. coli DH10B. Subsequently used for production purposes: 83% increase in




32 E. coli strains (Isaacs et al., 2011) [8] Replaced 314 TAG (stop) codons with TAA
E. coli MG1655 (Lajoie et al., 2013) [22] Replaced 321 UAG (stop) codons with UAA
rE. coli-57 (Ostrov et al., 2016) [119] Replaced 62214 instances of seven codons (UAG (stop), AGG and AGA (Arg), AGC and AGU (Ser),
UUG and UUA (Leu))
E. coli C123 (Napolitano et al., 2016) [128] Replaced 123 rare AGA and AGG (Arg) codons from essential genes with 110 CGU conversions and
13 optimised codon substitutions
E. coli MDS42 (Wang et al., 2016) [129] Tested 1468 codon changes using REXER technology and GENESIS method
S. cerevisiae Sc2.0 (Richardson et al., 2017) [130] Replaced TAG (stop) codons with TAA
E. coli Syn61 (Fredens et al., 2019) [131] Replaced 18214 codons, TCG with AGC, TCA with AGT, TAG with TAA, using REXER technology and
GENESIS method
of multiple minimal genomes for individual bacterial species, depending on environmental conditions [26,105], and
the selection of redundant genetic pathways in the cell [14].
Research for understanding (minimal genomes) and production (chassis development) (see Table 3) both involve
large numbers of gene/base pair deletions and use similar genetic tools. However, they differ in intent: no single gene
can be removed without loss of viability in minimal genomes [20], whereas the cellular growth rate is maintained or
promoted in chassis development. Additionally, minimal genome research focuses on protein-coding genes ignoring:
essential promoter regions, tRNAs, small non-coding RNAs [26], regulatory non-coding sequences [103], and the
physical layout of the genome [103,111], which are of interest to chassis development. Finally, bacterial species that do
not have a use industrially are of use in minimal genome research. Mycoplasma genitalium only synthesises DNA,
RNA, and proteins from imported precursors, in order to replicate itself [20], which it does slowly in a stress-free
laboratory environment [106]; useful for understanding but not for industry.
Of the largest scale reductions to date (see Table 3): JCVI-Syn3.0 [106], and B. subtilis PG10 and PS38 [112] were
produced for the purposes of understanding, and E. coli  33a [113] and E. coli DGF-298 [9] were produced as
chassis cells for production. Regardless of original intent, minimal genome reduction strains can have emergent ben-
eficial properties [114,115] (see Table 3) in addition to the lowermetabolic burden and increasedmetabolic efficiency
produced by reducing gene numbers [116]. Additionally, the reduced internal biochemistry may interfere less with
introduced external pathways [117], making for improved chassis cells. Two minimal genome reduction strains have
been subsequently used for production purposes (see Table 3).
Research for reducing risks (genome recoding) substitutes synonymous codons (encoding the same amino acid)
across an entire genome resulting in: virus resistance (viral replication relies on all 64 codons [21]), prevention of gene
transfer [118], and increased translation efficiency [8]. It also produces a blank codon that can be repurposed for a
novel function not commonly found in nature [8,21,119]. This incorporation of non-standard amino acid (NSAA) is
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Table 4 Features of an optimal chassis for a wide range of applications
Feature Description
Genetically stable Removal of mobile DNA elements (e.g. insertion elements, transposases, phages, integrases, site-speciﬁc
recombinases) [132]
Genomically recoded Substitute codons to create blank codons for inclusion of new, non-natural amino acids [8], decreased
likelihood of viral infection [21], and horizontal gene transfer [118]
Genome minimised Removal of competing and unwanted metabolic pathways that divert the resources of the cell away from
desired end products [19], resulting in increased capacity for and reduced impact of cellular burden [133,134],
and greater robustness and energy efﬁciency [135]. Also reducing transcriptional regulatory interactions
resulting in lower resistance to engineering efforts [132]. Additionally, allows exploitation of larger and optimal
precursor pools [136]
Production efﬁciency Simple nutritional needs, fast and efﬁcient growth, and efﬁcient secretion systems [6]
Robustness Tolerance for extreme conditions [6] i.e. strength of cell membrane or wall and appropriate coping
mechanisms [26]
Well understood Sufﬁcient knowledge of the organism’s genome and metabolism to produce accurate mathematical models
and modularisation of metabolic pathways [26].
Developed tools A range of established genetic tools for manipulation, including promoters and terminators with varying
expression levels, and well-characterised plasmids, to enable titre, rate, and yield improvements and rapid and
efﬁcient tuning of genetic components [19]
a form of biocontainment, further reducing risk, as the organism is engineered to be dependent upon the presence of
the synthetic NSAA to survive.
Genome recoding is possible due to the development of MAGE (multiplex automated genome engineering) [120]
and CAGE (conjugative assembly genome engineering) [8,121], and subsequently REXER [129]. MAGE cyclically
targets many genetic locations to conduct mismatches, insertions, deletions in a single cell or across a population of
cells, maintaining high efficiency of up to ten targets at a time [120]. This leads to rapid and continuous generation
of genetic diversity for strain and pathway engineering. CAGE is a complementary method, assembling modified
genomic modules from individual cells into a single genome through cell to cell transfer, and has been used in com-
bination with MAGE to systematically recode codons [8,121].
Combining genome engineering research together can give insights into what an ‘optimal’ cellular chassis could
look like (see Table 4) and suggest research pathways going forward.
Genome engineering in silico
Whole-cell models
The first whole-cell model [137] has been produced recently and is an important development for in silico cellular
research, as the first integration of mathematical models to simulate an entire cell’s components. The recency is due
to the immense complexity of individual cells. There are many well-characterised cellular subsystem models, such
as ordinary differential equation (ODE) or network models for protein interactions [138], but combining different
subsystems together has only been feasible in the last decade.
TheMycoplasmagenitalium whole-cell model [13] consists of 28 linked submodels that simulate different cellular
processes e.g. metabolism using FBA and cell division using ODEs. The model is implemented in MATLAB and
produces large amounts of output data. Genes can be knocked out of the model, and environmental variables altered,
so the cellular behaviour can be examined in various different situations.
A recent application of theM. genitalium whole-cell model is in silico genome reduction [14]. This is due to the
ease and low cost of simulations (with the appropriate computational infrastructure) compared with in vivo experi-
ments. Although modelling is never 100% accurate, it can help to shed light on unexplained phenomena and guide
the design of lab experiments, producing research more efficiently [139]. However, even with a genome as small as
M. genitalium (525 genes), the number of possible gene knockout combinations at genome-scale is of the order of
ten [127], making simulating every knockout set unattainable due to time and computational constraints.
Algorithms to reduce the solution space can be used. Minesweeper and GAMA (Guess Add Mate Algorithm) [14]
identified up to 165 genes that can be removed from the M. genitalium genome while still producing a dividing in
silico cell. Minesweeper approximates a divide-and-conquer algorithm by knocking out gene sets of varying sizes,
then combining sets that produced a dividing cell, generating knockout sets of greater size (thus a smaller genome).
GAMA begins similarly, knocking out gene sets of varying sizes, followed by a genetic algorithm to combine these
sets iteratively over multiple generations, to make the genome smaller.
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These approaches are similar to the metaheuristic algorithms used for metabolic engineering, they are purely in-
put/output dependent. These algorithms could potentially be applied to any model, regardless of its formulation, so
theoretically scalable from the GEM level to the whole-cell model level. OptGene and GAMA both use a genetic algo-
rithm to achieve their results, except with a different objective function. It is plausible that GAMA could be modified
to maximise a metabolite at the whole-cell level, and equally possible that FOCuS and GACOFBA could be applied
to whole-cell models for similar purposes or for genome minimisation.
Whole-cell models are a vital new approach for genome design. Combined with flexible algorithms (e.g. genetic
algorithms [140] and ant colony optimisation [141]) they can suggest genetic modifications to produce organisms
designed for specific purposes, while producing greater understanding of cellular processes and genetic interactions.
Issues
There is a clear need for greater species-specific understanding of the metabolism and the genome. Even well-studied
organisms (B. subtilis and E. coli) have genes with unknown functions and essentiality; bacterial genomes have on an
average 33% genes of unknown function [142]. Of the genes with known functions, in most cases we only understand
essentiality at the single or double knockout level [143,144]. Current genome reductions have had to identify synthetic
lethal interactions as part of their reduction efforts, rather than being able to design around them. If we had a greater
grasp of gene product interactions, enabling them to be accurately modelled, this could be avoided. We would also
be taking steps towards a proposed end goal of genome design, combining modular components of different bacteria
in a novel cell [24,145].
Another approach for genome-driven cell engineering, constructing bacterial genomes from scratch and insert-
ing them into a host cell, is not currently possible in the majority of bacteria due to economic and technological
constraints. Economically, bacterial genome production is too expensive for most institutes. Producing JCVI-Syn1.0
was estimated to cost ∼$40,000,000 [146]. Technologically, megabase-sized genomes can be constructed in yeast
[147,148], however successful genome transplantation has only been demonstrated in a fewMycoplasmas [149–151].
Development of whole-cell models for genome engineering is time and cost intensive. The M. genitalium
whole-cell model took 10-person years to build [152], resulting in the Karr Lab atMount Sinai developing automation
tools (Datanator and WC-Lang [153]) along the lines of automated tools for producing GSMMs.
Currently, genome engineering has not combined computational and biological research, due to how recently the
required tools were developed [13–16] and the difficulty of working withM. genitalium in the lab [106]. This is set
to change with the upcoming publication of an E. coli whole-cell model, as well as other whole-cell models [154]. In
combinationwith compatible genome design algorithms [14] thismight allow integrated in silico and in vivo genome
engineering for the first time.
Conclusions
Combining in silico and in vivo researchwill soon be possible in genome engineering.With the release of increasingly
refined whole-cell models, genome engineers will have an appropriate model, computational design algorithms, and
scalable genetic editing technologies. Following the path of metabolic engineering, better design, and construction
processes in silico and in vivo could be applied to a larger scale problem, replacing large quantities of lab work.
The next steps for genome engineering are: (i) the production and publication of new whole-cell models [154];
(ii) the implementation of computational standards to keep the field cohesive and prevent fragmentation [155]; (iii)
the testing of in silico designs in vivo [14]; (iv) and the establishment of routine procedures for in vivo genome
reductions for species that will soon have whole-cell models.
Summary
• Metabolic engineering has an established process of in silico design and in vivo construction.
• In silico design informing in vivo construction is the future of genome engineering.
• Whole-cell models and algorithms for genome design will widen the field of genome engineering.
• Testing current in silico predictions in vivo, and uniting in silico and in vivo research in E. coli, are
the next steps in genome engineering.
278 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
Acknowledgments
We would like to thank Oliver Chalkley for his biologist-appropriate explanations of Metabolic Engineering modelling and algo-
rithms, and advice on the paper.
Competing Interests
The authors declare that there are no competing interests associated with the manuscript.
Data Access Statement
The present study did not generate any new data.
Funding
This work was supported by the Medical Research Council [grant number MR/N021444/1 (to L.M.)]; the Engineering and Physical
Sciences Research Council [grant number EP/R041695/1 (to L.M.)]; the BBSRC/EPSRC Synthetic Biology Research Centre [grant
number BB/L01386X/1 (to L.M. and C.G.), flexi-fund grant]; ans the EPSRC Future Opportunity Ph.D. Scholarships (to S.L. and
J.R-G.).
Author Contribution
C.G., J.RG., S.L., and L.M. were involved in ideation and editing of the paper. S.L. was responsible for Metabolic Engineering in
silico, Genome Engineering in silico, Figures 1–5, and contributed to Issues. J.RG. was responsible for Introduction, Metabolic
Engineering in vivo, Genome Engineering in vivo, Figure 6, Issues, and Conclusion.
Abbreviations
CAGE, conjugative assembly genome engineering; COBRA, constraint-based reconstruction and analysis; FBA, flux balance
analysis; FOCuS, flower pollination coupled clonal selection algorithm; GAMA, guess add mate algorithm; GACOFBA, ge-
netic ant colony optimisation flux balance analysis; GDLS, genetic design through local search; GSMM/GEM, genome-scale
metabolic model; KEGG, Kyoto encyclopedia of genes and genomes; MAGE, multiplex automated genome engineering; ME,
macromolecular expression; MOMA, minimisation of metabolic adjustment; NOGD, non-orthologous gene displacement; NSAA,
non-standard amino acid; ODE, ordinary differential equation; ROOM, regulatory on/off minimisation of metabolic flux.
References
1 Serrano, L. (2007) Synthetic biology: promises and challenges. Mol. Syst. Biol. 3, 158, https://doi.org/10.1038/msb4100202
2 Huang, W.E. and Nikel, P.I. (2019) The Synthetic Microbiology Caucus: from abstract ideas to turning microbes into cellular machines and back.
Microb. Biotechnol. 12, 5–7, https://doi.org/10.1111/1751-7915.13337
3 O’Malley, M.A., Powell, A., Davies, J.F. and Calvert, J. (2008) Knowledge-making distinctions in synthetic biology. Bioessays 30, 57–65,
https://doi.org/10.1002/bies.20664
4 Brophy, J.A.N. and Voigt, C.A. (2014) Principles of genetic circuit design. Nat. Methods 11, 508–520, https://doi.org/10.1038/nmeth.2926
5 Dzieciol, A.J. and Mann, S. (2012) Designs for life: protocell models in the laboratory. Chem. Soc. Rev. 41, 79–85,
https://doi.org/10.1039/C1CS15211D
6 Calero, P. and Nikel, P.I. (2019) Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional
microorganisms. Microb. Biotechnol. 12, 98–124, https://doi.org/10.1111/1751-7915.13292
7 Endy, D. (2005) Foundations for engineering biology. Nature 438, 449–453, https://doi.org/10.1038/nature04342
8 Isaacs, F.J. (2011) Precise manipulation of chromosomes in vivo enables genome-wide codon replacement. Science 333, 348–353,
https://doi.org/10.1126/science.1205822
9 Hirokawa, Y. (2013) Genetic manipulations restored the growth ﬁtness of reduced-genome Escherichia coli. J. Biosci. Bioeng. 116, 52–58,
https://doi.org/10.1016/j.jbiosc.2013.01.010
10 Kim, T.Y., Sohn, S.B., Kim, Y.B., Kim, W.J. and Lee, S.Y. (2012) Recent advances in reconstruction and applications of genome-scale metabolic models.
Curr. Opin. Biotechnol. 23, 617–623, https://doi.org/10.1016/j.copbio.2011.10.007
11 Xu, N., Ye, C. and Liu, L. (2018) Genome-scale biological models for industrial microbial systems. Appl. Microbiol. Biotechnol. 102, 3439–3451,
https://doi.org/10.1007/s00253-018-8803-1
12 Nielsen, J. and Keasling, J.D. (2016) Engineering cellular metabolism. Cell 164, 1185–1197, https://doi.org/10.1016/j.cell.2016.02.004
13 Karr, J.R. (2012) A whole-cell computational model predicts phenotype from genotype. Cell 150, 389–401,
https://doi.org/10.1016/j.cell.2012.05.044
14 Rees, J., Chalkley, O., Purcell, O., Marucci, L. and Grierson, C. (2018) Designing genomes using design-simulate-test cycles. bioRxiv,
https://doi.org/10.1101/344564
15 Wang, L. and Maranas, C.D. (2018) MinGenome: an in silico top-down approach for the synthesis of minimized genomes. ACS Synth. Biol. 7,
462–473, https://doi.org/10.1021/acssynbio.7b00296
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
279
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
16 Jiang, W.Y., Bikard, D., Cox, D., Zhang, F. and Marrafﬁni, L.A. (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat.
Biotechnol. 31, 233–239, https://doi.org/10.1038/nbt.2508
17 Zhao, D. (2017) CRISPR/Cas9-assisted gRNA-free one-step genome editing with no sequence limitations and improved targeting efﬁciency. Sci. Rep.
7, 16624, https://doi.org/10.1038/s41598-017-16998-8
18 Zerbini, F. (2017) Large scale validation of an efﬁcient CRISPR/Cas-based multi gene editing protocol in Escherichia coli. Microb. Cell Fact. 16, 68,
https://doi.org/10.1186/s12934-017-0681-1
19 Carr, P.A. and Church, G.M. (2009) Genome engineering. Nat. Biotechnol. 27, 1151–1162, https://doi.org/10.1038/nbt.1590
20 Glass, J.I., Merryman, C., Wise, K.S., Hutchison, III, C.A. and Smith, H.O. (2017) Minimal cells-real and imagined. Cold Spring Harb. Perspect. Biol. 9,
a023861, https://doi.org/10.1101/cshperspect.a023861
21 Kohman, R.E., Kunjapur, A.M., Hysolli, E., Wang, Y. and Church, G.M. (2018) From designing the molecules of life to designing life: future applications
derived from advances in DNA technologies. Angew. Chem. Int. Ed. Engl. 57, 4313–4328, https://doi.org/10.1002/anie.201707976
22 Lajoie, M.J. et al. (2013) Genomically recoded organisms expand biological functions. Science 342, 357–360,
https://doi.org/10.1126/science.1241459
23 Adams, B.L. (2016) The next generation of synthetic biology chassis: moving synthetic biology from the laboratory to the ﬁeld. ACS Synth. Biol. 5,
1328–1330, https://doi.org/10.1021/acssynbio.6b00256
24 Vickers, C.E., Blank, L.M. and Kro¨mer, J.O. (2010) Grand challenge commentary: Chassis cells for industrial biochemical production. Nat. Chem. Biol.
6, 875–877, https://doi.org/10.1038/nchembio.484
25 Foley, P.L. and Shuler, M.L. (2010) Considerations for the design and construction of a synthetic platform cell for biotechnological applications.
Biotechnol. Bioeng. 105, 26–36, https://doi.org/10.1002/bit.22575
26 Xavier, J.C., Patil, K.R. and Rocha, I. (2014) Systems biology perspectives on minimal and simpler cells. Microbiol. Mol. Biol. Rev. 78, 487–509,
https://doi.org/10.1128/MMBR.00050-13
27 Thompson, D.B. (2018) The future of multiplexed eukaryotic genome engineering. ACS Chem. Biol. 13, 313–325,
https://doi.org/10.1021/acschembio.7b00842
28 Feist, A.M. and Palsson, B.Ø. (2008) The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat.
Biotechnol. 26, 659–667, https://doi.org/10.1038/nbt1401
29 Thiele, I. and Palsson, B.Ø. (2010) A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93–121,
https://doi.org/10.1038/nprot.2009.203
30 Paddon, C.J. et al. (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528–532,
https://doi.org/10.1038/nature12051
31 Deltcheva, E. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602,
https://doi.org/10.1038/nature09886
32 Jinek, M. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821,
https://doi.org/10.1126/science.1225829
33 Pontrelli, S. (2018) Escherichia coli as a host for metabolic engineering. Metab. Eng. 50, 16–46, https://doi.org/10.1016/j.ymben.2018.04.008
34 Gu, Y. (2018) Advances and prospects of Bacillus subtilis cellular factories: from rational design to industrial applications. Metab. Eng. 50, 109–121,
https://doi.org/10.1016/j.ymben.2018.05.006
35 Biggs, B.W., De Paepe, B., Santos, C. N.S., De Mey, M. and Kumaran Ajikumar, P. (2014) Multivariate modular metabolic engineering for pathway and
strain optimization. Curr. Opin. Biotechnol. 29, 156–162, https://doi.org/10.1016/j.copbio.2014.05.005
36 Chen, X., Li, S. and Liu, L. (2014) Engineering redox balance through cofactor systems. Trends Biotechnol 32, 337–343,
https://doi.org/10.1016/j.tibtech.2014.04.003
37 Conrado, R.J. (2012) DNA-guided assembly of biosynthetic pathways promotes improved catalytic efﬁciency. Nucleic Acids Res. 40, 1879–1889,
https://doi.org/10.1093/nar/gkr888
38 Gu, Y. (2017) Rewiring the glucose transportation and central metabolic pathways for overproduction of N-acetylglucosamine in Bacillus subtilis.
Biotechnol. J. 12, 1700020, https://doi.org/10.1002/biot.201700020
39 Hemberger, S. (2011) RibM from Streptomyces davawensis is a riboﬂavin/roseoﬂavin transporter and may be useful for the optimization of riboﬂavin
production strains. BMC Biotechnol. 11, 119, https://doi.org/10.1186/1472-6750-11-119
40 Liu, Y. (2016) A dynamic pathway analysis approach reveals a limiting futile cycle in N-acetylglucosamine overproducing Bacillus subtilis. Nat.
Commun. 7, 11933, https://doi.org/10.1038/ncomms11933
41 Portnoy, V.A., Bezdan, D. and Zengler, K. (2011) Adaptive laboratory evolution–harnessing the power of biology for metabolic engineering. Curr. Opin.
Biotechnol. 22, 590–594, https://doi.org/10.1016/j.copbio.2011.03.007
42 Wisselink, H.W., Toirkens, M.J., Wu, Q., Pronk, J.T. and van Maris, A.J.A. (2009) Novel evolutionary engineering approach for accelerated utilization of
glucose, xylose, and arabinose mixtures by engineered Saccharomyces cerevisiae strains. Appl. Environ. Microbiol. 75, 907–914,
https://doi.org/10.1128/AEM.02268-08
43 Wright, J. (2011) Batch and continuous culture-based selection strategies for acetic acid tolerance in xylose-fermenting Saccharomyces cerevisiae.
FEMS Yeast Res. 11, 299–306, https://doi.org/10.1111/j.1567-1364.2011.00719.x
44 Singh, R., Kumar, M., Mittal, A. and Mehta, P.K. (2016) Microbial enzymes: industrial progress in 21st century. 3 Biotech 6, 174,
https://doi.org/10.1007/s13205-016-0485-8
45 Kim, O.D., Rocha, M. and Maia, P. (2018) A review of dynamic modeling approaches and their application in computational strain optimization for
metabolic engineering. Front. Microbiol. 9, 1690, https://doi.org/10.3389/fmicb.2018.01690
46 Orth, J.D., Thiele, I. and Palsson, B.O. (2010) What is ﬂux balance analysis? Nat. Biotechnol. 28, 245–248, https://doi.org/10.1038/nbt.1614
280 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
47 Systems Biology UCSD (2018) Systems Biology UCSD Database. Systems Biology UCSD,
http://systemsbiology.ucsd.edu/InSilicoOrganisms/OtherOrganisms
48 Devoid, S. (2013) Automated genome annotation and metabolic model reconstruction in the SEED and Model SEED. Methods Mol. Biol. 985, 17–45,
https://doi.org/10.1007/978-1-62703-299-5˙2
49 Machado, D., Andrejev, S., Tramontano, M. and Patil, K.R. (2018) Fast automated reconstruction of genome-scale metabolic models for microbial
species and communities. Nucleic Acids Res. 46, 7542–7553, https://doi.org/10.1093/nar/gky537
50 BiGG Models (2018) BiGG Models: A platform for integrating, standardizing, and sharing genome-scale models. Systems Biology UCSD,
http://bigg.ucsd.edu/
51 King, Z.A. (2015) BiGG Models: a platform for integrating, standardizing and sharing genome-scale models. Nucleic Acids Res. 44, D515–D522,
https://doi.org/10.1093/nar/gkv1049
52 Aite, M. (2018) Traceability, reproducibility and wiki-exploration for ‘a`-la-carte’ reconstructions of genome-scale metabolic models. PLoS Comput.
Biol. 14, e1006146, https://doi.org/10.1371/journal.pcbi.1006146
53 Dias, O., Rocha, M., Ferreira, E.C. and Rocha, I. (2010) Merlin: metabolic models reconstruction using genome-scale information. IFAC Proc. Vol. 43,
120–125, https://doi.org/10.3182/20100707-3-BE-2012.0076
54 Olivier, B.G. (2018) MetaToolkit: MetaDraft. https://systemsbioinformatics.github.io/cbmpy-metadraft/
55 Karp, P.D. (2016) Pathway Tools version 19.0 update: software for pathway/genome informatics and systems biology. Brief. Bioinform. 17, 877–890,
https://doi.org/10.1093/bib/bbv079
56 Wang, H. (2018) RAVEN 2.0: a versatile toolbox for metabolic network reconstruction and a case study on Streptomyces coelicolor. PLoS Comput. Biol.
14, e1006541, https://doi.org/10.1371/journal.pcbi.1006541
57 Mendoza, S.N., Olivier, B.G., Molenaar, D. and Teusink, B. (2019) A systematic assessment of current genome-scale metabolic reconstruction tools.
bioRxiv, https://doi.org/10.1101/558411
58 Zanghellini, J., Ruckerbauer, D.E., Hanscho, M. and Jungreuthmayer, C. (2013) Elementary ﬂux modes in a nutshell: properties, calculation and
applications. Biotechnol. J. 8, 1009–1016, https://doi.org/10.1002/biot.201200269
59 Schellenberger, J. and Palsson, B.Ø. (2009) Use of randomized sampling for analysis of metabolic networks. J. Biol. Chem. 284, 5457–5461,
https://doi.org/10.1074/jbc.R800048200
60 Varma, A. and Palsson, B.O. (1994) Metabolic ﬂux balancing: basic concepts, scientiﬁc and practical use. Biotechnology 12, 994–998,
https://doi.org/10.1038/nbt1094-994
61 Knorr, A.L., Jain, R. and Srivastava, R. (2007) Bayesian-based selection of metabolic objective functions. Bioinformatics 23, 351–357,
https://doi.org/10.1093/bioinformatics/btl619
62 Lewis, N.E., Nagarajan, H. and Palsson, B.O. (2012) Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico
methods. Nat. Rev. Microbiol. 10, 291–305, https://doi.org/10.1038/nrmicro2737
63 Segre, D., Vitkup, D. and Church, G.M. (2002) Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl. Acad. Sci. U.S.A. 99,
15112–15117, https://doi.org/10.1073/pnas.232349399
64 Shlomi, T., Berkman, O. and Ruppin, E. (2005) Regulatory on/off minimization of metabolic ﬂux changes after genetic perturbations. Proc. Natl. Acad.
Sci. U.S.A. 102, 7695–7700, https://doi.org/10.1073/pnas.0406346102
65 Fong, S.S. and Palsson, B.Ø. (2004) Metabolic gene–deletion strains of Escherichia coli evolve to computationally predicted growth phenotypes. Nat.
Genet. 36, 1056, https://doi.org/10.1038/ng1432
66 Edwards, J.S. and Palsson, B.O. (2000) The Escherichia coli MG1655 in silico metabolic genotype: Its deﬁnition, characteristics, and capabilities. Proc.
Natl. Acad. Sci. U.S.A. 97, 5528–5533, https://doi.org/10.1073/pnas.97.10.5528
67 Schilling, C.H. (2002) Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 184, 4582–4593,
https://doi.org/10.1128/JB.184.16.4582-4593.2002
68 Fo¨rster, J., Famili, I., Palsson, B.Ø. and Nielsen, J. (2003) Large-scale evaluation of in silico gene deletions in Saccharomyces cerevisiae. OMICS 7,
193–202, https://doi.org/10.1089/153623103322246584
69 Oh, Y.-K., Palsson, B.O., Park, S.M., Schilling, C.H. and Mahadevan, R. (2007) Genome-scale reconstruction of metabolic network in Bacillus subtilis
based on high-throughput phenotyping and gene essentiality data. J. Biol. Chem. 282, 28791–28799, https://doi.org/10.1074/jbc.M703759200
70 Shinfuku, Y. (2009) Development and experimental veriﬁcation of a genome-scale metabolic model for Corynebacterium glutamicum. Microb. Cell
Fact. 8, 43, https://doi.org/10.1186/1475-2859-8-43
71 Lloyd, C.J. (2018) COBRAme: a computational framework for genome-scale models of metabolism and gene expression. PLoS Comput. Biol. 14,
e1006302, https://doi.org/10.1371/journal.pcbi.1006302
72 O’Brien, E.J., Lerman, J.A., Chang, R.L., Hyduke, D.R. and Palsson, B.Ø. (2013) Genome-scale models of metabolism and gene expression extend and
reﬁne growth phenotype prediction. Mol. Syst. Biol. 9, 693
73 Kanehisa, M. and Goto, S. (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30,
https://doi.org/10.1093/nar/28.1.27
74 Benson, D.A. (2012) GenBank. Nucleic Acids Res. 41, D36–D42, https://doi.org/10.1093/nar/gks1195
75 Hameri, T., Fengos, G., Ataman, M., Miskovic, L. and Hatzimanikatis, V. (2019) Kinetic models of metabolism that consider alternative steady-state
solutions of intracellular ﬂuxes and concentrations. Metab. Eng. 52, 29–41, https://doi.org/10.1016/j.ymben.2018.10.005
76 Becker, J., Zelder, O., Ha¨fner, S., Schro¨der, H. and Wittmann, C. (2011) From zero to hero—design-based systems metabolic engineering of
Corynebacterium glutamicum for l-lysine production. Metab. Eng. 13, 159–168, https://doi.org/10.1016/j.ymben.2011.01.003
77 Burgard, A.P., Pharkya, P. and Maranas, C.D. (2003) Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial
strain optimization. Biotechnol. Bioeng. 84, 647–657, https://doi.org/10.1002/bit.10803
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
281
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
78 Kim, J. and Reed, J.L. (2010) OptORF: optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains. BMC Syst. Biol.
4, 53, https://doi.org/10.1186/1752-0509-4-53
79 Tepper, N. and Shlomi, T. (2009) Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways.
Bioinformatics 26, 536–543, https://doi.org/10.1093/bioinformatics/btp704
80 Xu, Z., Zheng, P., Sun, J. and Ma, Y. (2013) ReacKnock: identifying reaction deletion strategies for microbial strain optimization based on
genome-scale metabolic network. PLoS ONE 8, e72150, https://doi.org/10.1371/journal.pone.0072150
81 Ye, J.J. and Zhu, D.L. (1995) Optimality conditions for bilevel programming problems. Optimization 33, 9–27,
https://doi.org/10.1080/02331939508844060
82 Yang, L., Cluett, W.R. and Mahadevan, R. (2011) EMILiO: a fast algorithm for genome-scale strain design. Metab. Eng. 13, 272–281,
https://doi.org/10.1016/j.ymben.2011.03.002
83 Pharkya, P. and Maranas, C.D. (2006) An optimization framework for identifying reaction activation/inhibition or elimination candidates for
overproduction in microbial systems. Metab. Eng. 8, 1–13, https://doi.org/10.1016/j.ymben.2005.08.003
84 Ranganathan, S., Suthers, P.F. and Maranas, C.D. (2010) OptForce: an optimization procedure for identifying all genetic manipulations leading to
targeted overproductions. PLoS Comput. Biol. 6, e1000744, https://doi.org/10.1371/journal.pcbi.1000744
85 Glover, F.W. and Kochenberger, G.A. (2006) Handbook of Metaheuristics, Springer Science & Business Media
86 Patil, K.R., Rocha, I., Fo¨rster, J. and Nielsen, J. (2005) Evolutionary programming as a platform for in silico metabolic engineering. BMC Bioinformatics
6, 308, https://doi.org/10.1186/1471-2105-6-308
87 Xu, Z. (2018) RegKnock: identifying gene knockout strategies for microbial strain optimization based on regulatory and metabolic integrated network.
bioRxiv, https://doi.org/10.1101/438168
88 Covert, M.W. and Palsson, B.Ø. (2002) Transcriptional regulation in constraints-based metabolic models of Escherichia coli. J. Biol. Chem. 277,
28058–28064, https://doi.org/10.1074/jbc.M201691200
89 Mutturi, S. (2017) FOCuS: a metaheuristic algorithm for computing knockouts from genome-scale models for strain optimization. Mol. Biosyst. 13,
1355–1363, https://doi.org/10.1039/C7MB00204A
90 Yang, X.-S. (2012) Flower pollination algorithm for global optimization. International Conference on Unconventional Computing and Natural
Computation, pp. 240–249, Springer
91 De Castro, L.N. and Von Zuben, F.J. (2000) The clonal selection algorithm with engineering applications. Proc. GECCO 2000, 36–39
92 Salleh, A.H.M (2015) Gene knockout identiﬁcation for metabolite production improvement using a hybrid of genetic ant colony optimization and ﬂux
balance analysis. Biotechnol. Bioprocess Eng. 20, 685–693, https://doi.org/10.1007/s12257-015-0276-9
93 Pharkya, P., Burgard, A.P. and Maranas, C.D. (2004) OptStrain: a computational framework for redesign of microbial production systems. Genome Res
14, 2367–2376, https://doi.org/10.1101/gr.2872004
94 Lun, D.S. (2009) Large-scale identiﬁcation of genetic design strategies using local search. Mol. Syst. Biol. 5, 296,
https://doi.org/10.1038/msb.2009.57
95 Fleischmann, R.D. (1995) Whole-genome random sequencing and assembly of Haemophilus inﬂuenzae Rd. Science 269, 496–512,
https://doi.org/10.1126/science.7542800
96 Fraser, C.M. (1995) The minimal gene complement of mycoplasma-genitalium. Science 270, 397–403,
https://doi.org/10.1126/science.270.5235.397
97 Mushegian, A.R. and Koonin, E.V. (1996) A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc. Natl. Acad.
Sci. U.S.A. 93, 10268–10273, https://doi.org/10.1073/pnas.93.19.10268
98 Gil, R., Silva, F.J., Pereto, J. and Moya, A. (2004) Determination of the core of a minimal bacterial gene set. Microbiol. Mol. Biol. Rev. 68, 518–537
99 Shuler, M.L., Foley, P. and Atlas, J. (2012) Modeling a minimal cell. In Microbial Systems Biology (Navid, A., ed.), vol. 881, pp. 573–610, Humana
Press
100 Lagesen, K., Ussery, D.W. and Wassenaar, T.M. (2010) Genome update: the 1000th genome - a cautionary tale. Microbiology 156, 603–608,
https://doi.org/10.1099/mic.0.038257-0
101 Liu, W. (2012) Comparative genomics of Mycoplasma: analysis of conserved essential genes and diversity of the pan-genome. PLoS ONE 7, e35698,
https://doi.org/10.1371/journal.pone.0035698
102 Acevedo-Rocha, C.G., Fang, G., Schmidt, M., Ussery, D.W. and Danchin, A. (2013) From essential to persistent genes: a functional approach to
constructing synthetic life. Trends Genet. 29, 273–279, https://doi.org/10.1016/j.tig.2012.11.001
103 Gil, R. (2006) The minimal gene-set machinery. In Encyclopedia of Molecular Cell Biology and Molecular Medicine (Meyers, R.A., ed.), Wiley-VCH
Verlag GmbH & Co. KGaA
104 D’Elia, M.A., Pereira, M.P. and Brown, E.D. (2009) Are essential genes really essential? Trends Microbiol. 17, 433–438,
https://doi.org/10.1016/j.tim.2009.08.005
105 Rancati, G., Moffat, J., Typas, A. and Pavelka, N. (2018) Emerging and evolving concepts in gene essentiality. Nat. Rev. Genet. 19, 34–49,
https://doi.org/10.1038/nrg.2017.74
106 Hutchison, C.A. et al. (2016) Design and synthesis of a minimal bacterial genome. Science 351, aad6523, https://doi.org/10.1126/science.aad6253
107 Kaelin, Jr, W.G. (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5, 689–698,
https://doi.org/10.1038/nrc1691
108 Nijman, S.M.B. (2011) Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett. 585, 1–6,
https://doi.org/10.1016/j.febslet.2010.11.024
109 Smalley, D.J., Whiteley, M. and Conway, T. (2003) In search of the minimal Escherichia coli genome. Trends Microbiol. 11, 6–8,
https://doi.org/10.1016/S0966-842X(02)00008-2
282 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
110 Motter, A.E., Gulbahce, N., Almaas, E. and Baraba´si, A.-L. (2008) Predicting synthetic rescues in metabolic networks. Mol. Syst. Biol. 4, 168,
https://doi.org/10.1038/msb.2008.1
111 Mushegian, A. (1999) The minimal genome concept. Curr. Opin. Genet. Dev. 9, 709–714, https://doi.org/10.1016/S0959-437X(99)00023-4
112 Reuß, D.R. (2017) Large-scale reduction of the Bacillus subtilis genome: consequences for the transcriptional network, resource allocation, and
metabolism. Genome Res. 27, 289–299, https://doi.org/10.1101/gr.215293.116
113 Iwadate, Y., Honda, H., Sato, H., Hashimoto, M. and Kato, J.-I. (2011) Oxidative stress sensitivity of engineered Escherichia coli cells with a reduced
genome. FEMS Microbiol. Lett. 322, 25–33, https://doi.org/10.1111/j.1574-6968.2011.02331.x
114 Mizoguchi, H., Sawano, Y., Kato, J. and Mori, H. (2008) Superpositioning of deletions promotes growth of Escherichia coli with a reduced genome.
DNA Res. 15, 277–284, https://doi.org/10.1093/dnares/dsn019
115 Moya, A. (2009) Toward minimal bacterial cells: evolution vs. design. FEMS Microbiol. Rev. 33, 225–235,
https://doi.org/10.1111/j.1574-6976.2008.00151.x
116 Lee, J.H. (2009) Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production. Microb. Cell Fact. 8, 2,
https://doi.org/10.1186/1475-2859-8-2
117 Martı´nez-Garcı´a, E. and de Lorenzo, V. (2016) The quest for the minimal bacterial genome. Curr. Opin. Biotechnol. 42, 216–224,
https://doi.org/10.1016/j.copbio.2016.09.001
118 Wang, L. (2018) Synthetic genomics: from DNA synthesis to genome design. Angew. Chem. Int. Ed. Engl. 57, 1748–1756,
https://doi.org/10.1002/anie.201708741
119 Ostrov, N. (2016) Design, synthesis, and testing toward a 57-codon genome. Science 353, 819–822, https://doi.org/10.1126/science.aaf3639
120 Wang, H.H. (2009) Programming cells by multiplex genome engineering and accelerated evolution. Nature 460, 894–898,
https://doi.org/10.1038/nature08187
121 Ma, N.J., Moonan, D.W. and Isaacs, F.J. (2014) Precise manipulation of bacterial chromosomes by conjugative assembly genome engineering. Nat.
Protoc. 9, 2285–2300, https://doi.org/10.1038/nprot.2014.081
122 Aguilar Suarez, R., Stu¨lke, J. and van Dijl, J.M. (2019) Less is more: towards a genome-reduced Bacillus cell factory for ‘difﬁcult proteins’. ACS Synth.
Biol. 8, 99–108, https://doi.org/10.1021/acssynbio.8b00342
123 Hashimoto, M. (2005) Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome. Mol. Microbiol. 55, 137–149,
https://doi.org/10.1111/j.1365-2958.2004.04386.x
124 Ara, K. (2007) Bacillus minimum genome factory: effective utilization of microbial genome information. Biotechnol. Appl. Biochem. 46, 169–178,
https://doi.org/10.1042/BA20060111
125 Morimoto, T. (2008) Enhanced recombinant protein productivity by genome reduction in Bacillus subtilis. DNA Res. 15, 73–81,
https://doi.org/10.1093/dnares/dsn002
126 Park, M.K. (2014) Enhancing recombinant protein production with an Escherichia coli host strain lacking insertion sequences. Appl. Microbiol.
Biotechnol. 98, 6701–6713, https://doi.org/10.1007/s00253-014-5739-y
127 Posfai, G. (2006) Emergent properties of reduced-genome Escherichia coli. Science 312, 1044–1046, https://doi.org/10.1126/science.1126439
128 Napolitano, M.G. (2016) Emergent rules for codon choice elucidated by editing rare arginine codons in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A.
113, E5588–97, https://doi.org/10.1073/pnas.1605856113
129 Wang, K. (2016) Deﬁning synonymous codon compression schemes by genome recoding. Nature 539, 59–64, https://doi.org/10.1038/nature20124
130 Richardson, S.M. (2017) Design of a synthetic yeast genome. Science 355, 1040–1044, https://doi.org/10.1126/science.aaf4557
131 Fredens, J. (2019) Total synthesis of Escherichia coli with a recoded genome. Nature 569, 514–518, https://doi.org/10.1038/s41586-019-1192-5
132 Henry, C.S., Overbeek, R. and Stevens, R.L. (2010) Building the blueprint of life. Biotechnol. J. 5, 695–704, https://doi.org/10.1002/biot.201000076
133 Borkowski, O. (2018) Cell-free prediction of protein expression costs for growing cells. Nat. Commun. 9, 1457,
https://doi.org/10.1038/s41467-018-03970-x
134 Ceroni, F. and Ellis, T. (2018) The challenges facing synthetic biology in eukaryotes. Nat. Rev. Mol. Cell Biol. 19, 481–482,
https://doi.org/10.1038/s41580-018-0013-2
135 Mol, M., Kabra, R. and Singh, S. (2018) Genome modularity and synthetic biology: Engineering systems. Prog. Biophys. Mol. Biol. 132, 43–51,
https://doi.org/10.1016/j.pbiomolbio.2017.08.002
136 Park, S.Y., Yang, D., Ha, S.H. and Lee, S.Y. (2018) Metabolic engineering of microorganisms for the production of natural compounds. Adv. Biosys. 2,
1700190, https://doi.org/10.1002/adbi.201700190
137 Goldberg, A.P. (2018) Emerging whole-cell modeling principles and methods. Curr. Opin. Biotechnol. 51, 97–102,
https://doi.org/10.1016/j.copbio.2017.12.013
138 Przˇulj, N., Corneil, D.G. and Jurisica, I. (2004) Modeling interactome: scale-free or geometric. Bioinformatics 20, 3508–3515,
https://doi.org/10.1093/bioinformatics/bth436
139 Waltemath, D. and Wolkenhauer, O. (2016) How modeling standards, software, and initiatives support reproducibility in systems biology and systems
medicine. IEEE Trans. Biomed. Eng. 63, 1999–2006, https://doi.org/10.1109/TBME.2016.2555481
140 Davis, L. (1991) Handbook of Genetic Algorithms, 1st Edition, Van Nostrand Reinhold
141 Dorigo, M. and Di Caro, G. (1999) Ant colony optimization: a new meta-heuristic. Proceedings of the 1999 Congress on Evolutionary
Computation-CEC99 (Cat. No. 99TH8406), vol. 2, pp. 1470–1477, IEEE
142 Price, M.N. (2018) Mutant phenotypes for thousands of bacterial genes of unknown function. Nature 557, 503–509,
https://doi.org/10.1038/s41586-018-0124-0
143 Baba, T. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 1–11,
https://doi.org/10.1038/msb4100050
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
283
Essays in Biochemistry (2019) 63 267–284
https://doi.org/10.1042/EBC20180045
144 Butland, G. (2008) eSGA: E. coli synthetic genetic array analysis. Nat. Methods 5, 789–795, https://doi.org/10.1038/nmeth.1239
145 Gibson, D.G. (2014) Programming biological operating systems: genome design, assembly and activation. Nat. Methods 11, 521–526,
https://doi.org/10.1038/nmeth.2894
146 Sleator, R.D. (2010) The story of Mycoplasma mycoides JCVI-syn1.0: the forty million dollar microbe. Bioeng. Bugs 1, 229–230,
https://doi.org/10.4161/bbug.1.4.12465
147 Gibson, D.G. (2008) Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 319, 1215–1220,
https://doi.org/10.1126/science.1151721
148 Zhou, J., Wu, R., Xue, X. and Qin, Z. (2016) CasHRA (Cas9-facilitated Homologous Recombination Assembly) method of constructing megabase-sized
DNA. Nucleic Acids Res. 44, e124, https://doi.org/10.1093/nar/gkw475
149 Lartigue, C. (2007) Genome transplantation in bacteria: changing one species to another. Science 317, 632–638,
https://doi.org/10.1126/science.1144622
150 Lartigue, C. (2009) Creating bacterial strains from genomes that have been cloned and engineered in yeast. Science 325, 1693–1696,
https://doi.org/10.1126/science.1173759
151 Baby, V. (2018) Cloning and transplantation of the Mesoplasma ﬂorum genome. ACS Synth. Biol. 7, 209–217,
https://doi.org/10.1021/acssynbio.7b00279
152 Szigeti, B. (2018) A blueprint for human whole-cell modeling. Curr. Opin. Syst. Biol. 7, 8–15, https://doi.org/10.1016/j.coisb.2017.10.005
153 Karr, J. (2018) Tools for building, simulating, analyzing whole-cell models. Whole Cell Model., https://www.wholecell.org/tools/
154 Karr, J. (2018) Comprehensive whole-cell computational models of individual cells. Whole Cell Model., https://www.wholecell.org/models/
155 Waltemath, D. (2016) Toward community standards and software for whole-cell modeling. IEEE Trans. Biomed. Eng. 63, 2007–2014,
https://doi.org/10.1109/TBME.2016.2560762
284 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
